EUVIMED · CrossrefZeitschrift
Fibrosis
ISSN 2959-605X · SCIE Publishing Limited
Neueste Artikel
Hepatic Stellate Cells Interact with the Immune System: A Bidirectional Crosstalk Network Driving Liver Fibrosis
Molecular Targets and Emerging Therapeutics in Cardiac Fibrosis
Comparison of the Transcriptomic Signatures of Skin and Lung Fibroblasts from Patients with Systemic Sclerosis
Mitochondrial Fatty Acid Oxidation Dysfunction in Tubulointerstitial Fibrosis: Mechanisms and Therapeutic Advances
Intercellular Targetable Mechanistic Interface for Cardiac Fibrosis
Organoid Models of Liver Fibrosis: Bridging Genetic and Epigenetic Mechanisms with Biomarker Discovery
Navigating the Size Paradox: The Journey of a Procollagen Molecule from Liquid State to Fibrillar Matrix
Comparative Analysis of Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: Epidemiology, Pathophysiology, Clinical Features, Diagnosis and Treatment
Immunoprofiling of Alcohol-Activated Hepatic Stellate Cells Reveals Mechanisms of Immune Evasion through NK/T Lymphocyte Checkpoint Signaling
Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes
Fibrosis: A New Open-Access Journal to Share Your Research
Pulsed Ultraviolet C as a Potential Treatment for COVID-19
Established Hepatic Stellate Cell Lines in Hepatology Research
Comprehensive Landscape of Matrix Metalloproteinases in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Hepatic Lysosomal Enzyme Activity in Primary Biliary Cholangitis
The Severity of Isoproterenol-Induced Myocardial Fibrosis and Related Dysfunction in Mice Is Strain-Dependent
Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary Fibrosis
TANGO1 Dances to Export of Procollagen from the Endoplasmic Reticulum
The Cellular and Metabolic Bases of Organ Fibrosis: UNIA Workshop 2023 in Baeza, Spain
Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling
12th International Workshop on the CCN Family of Genes
Mitochondrial Damage and Epithelial-Mesenchymal Transition as Major Triggers of the Development of Idiopathic Pulmonary Fibrosis
A Review of the Current Landscape of Anti-Fibrotic Medicines
The Notch3 Pathway in Organ Fibrosis
Acute Exacerbations of Interstitial Lung Disease: Evolving Perspectives on Diagnosis and Management
Exploring the Potential Relationship between Gut Microbiome Metabolites and Idiopathic Pulmonary Fibrosis via Network Pharmacology Study
Dermal Fibrosis and the Current Scope of Hydrogel Strategies for Scarless Wound Healing
Perspectives of Drug Therapy for Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
Mechanics and Synergistic Signaling of Fibronectin, Integrins, and TGF-β Isoforms
The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review
EUVIMED